iOMEDICO conducts phase I-IV clinical trials and prospective tumor registries. Furthermore, as an academically oriented research institute, we focus on investigator-initiated trials (IIT). With oncological expertise from practices and clinics, as well as long-standing experience, we design high-quality research projects, which are a precise fit for the latest oncological challenges. Our aim is to pave the way for new treatment strategies for patients and to enhance the quality of therapy.
As a clinical research organisation (CRO), we offer you all the services of clinical research from a single source: from design to publication.
Joint research for all concerned
Medical research is a team effort. Close cooperation with national and international study groups and expert associations, the research-based pharmaceutical industry and a high performing investigator network contribute to the success of our projects. We support your research project likewise with our professional structures and partners – fast, competently and confidentially. Feel free to contact us with your request.
Translational research and precision oncology
Progress in molecular diagnostics allows us to understand the processes inside the tumor cell much better. Tumor profiles determine the treatment plan and possible study participation. Biobanking and cross-over analysis between clinical trial and real world data, helps to identify new treatment options that can be applied in a targeted and evidence-based manner.
Awards, distinctions and publications
iOMEDICO’s research results are presented and published nationally and internationally. They have won several awards, have been internationally recognized as clinically relevant and were selected for best abstract- or best of congress-sessions. We are committed to this high level of our research work.